The Therapeutic Potential of PhospholipaseA2 Inhibitors in Cardiovascular Disease

E-ISSN： 1875-6182|5|1|91-95

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.5, Iss.1, 2007-01, pp. : 91-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adrenomedullins: Therapeutic Potential in Cardiovascular Disease

Current Hypertension Reviews, Vol. 7, Iss. 4, 2011-12 ,pp. : 284-291

Bentham Science Publishers

Access to resources Recommend Favorite

Sodium–calcium exchange inhibitors: therapeutic potential in cardiovascular diseases

By Iwamoto Takahiro

Future Cardiology, Vol. 1, Iss. 4, 2005-07 ,pp. : 519-529

Future Medicine

Access to resources Recommend Favorite

The Endothelium and Platelets in Cardiovascular Disease: Potential Targets for Therapeutic Intervention

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 2, 2004-04 ,pp. : 169-178

Bentham Science Publishers

Access to resources Recommend Favorite

The P2Y₁₂ receptor as a therapeutic target in cardiovascular disease

By Storey R. F.

Platelets, Vol. 12, Iss. 4, 2001-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

Comparative roles of phospholipase A₂ isoforms in cardiovascular pathophysiology

By McHowat Jane Creer Michael

Cardiovascular Toxicology, Vol. 1, Iss. 4, 2001-12 ,pp. : 253-265

Humana Press, Inc

Access to resources Recommend Favorite